Fused Ring Dicationic Anti-Protozoan Agents and Their Products

David W. Boykin (Inventor), Richard R. Tidwell (Inventor), W. David Wilson (Inventor), Reto Brun (Inventor), Reem K. Arafa (Inventor), Chad E. Stephens (Inventor)

Research output: ResearchPatent

Abstract

Novel fused ring dicationic anti-protozoan compounds. Representative protozoan species include but are not limited to Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum. Prodrugs of these compounds can be used as an oral treatment for malaria and human African trypanosomiasis.
LanguageEnglish
Patent number7825279
IPCC07C 279/18 (20060101); C07D 219/12 (20060101); C07D 213/06 (20060101); A61K 31/155 (20060101); A61K 31/235 (20060101); A61K 31/24 (20060101); A61K 31/44 (20060101)
StatePublished - 1800

Fingerprint

Prodrugs

Cite this

Boykin, D. W., Tidwell, R. R., Wilson, W. D., Brun, R., Arafa, R. K., & Stephens, C. E. (1800). IPC No. C07C 279/18 (20060101); C07D 219/12 (20060101); C07D 213/06 (20060101); A61K 31/155 (20060101); A61K 31/235 (20060101); A61K 31/24 (20060101); A61K 31/44 (20060101). Fused Ring Dicationic Anti-Protozoan Agents and Their Products (Patent No. 7825279.)

Fused Ring Dicationic Anti-Protozoan Agents and Their Products. / Boykin, David W. (Inventor); Tidwell, Richard R. (Inventor); Wilson, W. David (Inventor); Brun, Reto (Inventor); Arafa, Reem K. (Inventor); Stephens, Chad E. (Inventor).

IPC No.: C07C 279/18 (20060101); C07D 219/12 (20060101); C07D 213/06 (20060101); A61K 31/155 (20060101); A61K 31/235 (20060101); A61K 31/24 (20060101); A61K 31/44 (20060101). Patent No.: 7825279.

Research output: ResearchPatent

Boykin, DW, Tidwell, RR, Wilson, WD, Brun, R, Arafa, RK & Stephens, CE 1800, Fused Ring Dicationic Anti-Protozoan Agents and Their Products, Patent No. 7825279, IPC No. C07C 279/18 (20060101); C07D 219/12 (20060101); C07D 213/06 (20060101); A61K 31/155 (20060101); A61K 31/235 (20060101); A61K 31/24 (20060101); A61K 31/44 (20060101).
Boykin DW, Tidwell RR, Wilson WD, Brun R, Arafa RK, Stephens CE, inventors. Fused Ring Dicationic Anti-Protozoan Agents and Their Products. C07C 279/18 (20060101); C07D 219/12 (20060101); C07D 213/06 (20060101); A61K 31/155 (20060101); A61K 31/235 (20060101); A61K 31/24 (20060101); A61K 31/44 (20060101). 1800
Boykin, David W. (Inventor) ; Tidwell, Richard R. (Inventor) ; Wilson, W. David (Inventor) ; Brun, Reto (Inventor) ; Arafa, Reem K. (Inventor) ; Stephens, Chad E. (Inventor). / Fused Ring Dicationic Anti-Protozoan Agents and Their Products. IPC No.: C07C 279/18 (20060101); C07D 219/12 (20060101); C07D 213/06 (20060101); A61K 31/155 (20060101); A61K 31/235 (20060101); A61K 31/24 (20060101); A61K 31/44 (20060101). Patent No.: 7825279.
@misc{72b6eeb78713467886b93c14c2cb85f2,
title = "Fused Ring Dicationic Anti-Protozoan Agents and Their Products",
abstract = "Novel fused ring dicationic anti-protozoan compounds. Representative protozoan species include but are not limited to Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum. Prodrugs of these compounds can be used as an oral treatment for malaria and human African trypanosomiasis.",
author = "Boykin, {David W.} and Tidwell, {Richard R.} and Wilson, {W. David} and Reto Brun and Arafa, {Reem K.} and Stephens, {Chad E.}",
note = "Status: published applicationnumber: 10/992,607 usclass: 564/235 ; 546/106; 546/306; 560/34; 560/8; 564/229; 564/238 applicationnumber: 10/992,607; 7825279; C07C 279/18 (20060101); C07D 219/12 (20060101); C07D 213/06 (20060101); A61K 31/155 (20060101); A61K 31/235 (20060101); A61K 31/24 (20060101); A61K 31/44 (20060101)",
year = "1800",
type = "Patent",

}

TY - PAT

T1 - Fused Ring Dicationic Anti-Protozoan Agents and Their Products

AU - Boykin,David W.

AU - Tidwell,Richard R.

AU - Wilson,W. David

AU - Brun,Reto

AU - Arafa,Reem K.

AU - Stephens,Chad E.

N1 - Status: published applicationnumber: 10/992,607 usclass: 564/235 ; 546/106; 546/306; 560/34; 560/8; 564/229; 564/238 applicationnumber: 10/992,607

PY - 1800

Y1 - 1800

N2 - Novel fused ring dicationic anti-protozoan compounds. Representative protozoan species include but are not limited to Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum. Prodrugs of these compounds can be used as an oral treatment for malaria and human African trypanosomiasis.

AB - Novel fused ring dicationic anti-protozoan compounds. Representative protozoan species include but are not limited to Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum. Prodrugs of these compounds can be used as an oral treatment for malaria and human African trypanosomiasis.

M3 - Patent

M1 - 7825279

ER -